Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

CRO

- PMLiVE

Positive trials bring Pfizer closer to new use for Xeljanz

Rheumatoid arthritis drug performs in two ulcerative colitis trials

- PMLiVE

Harnessing the power of ethnography in healthcare

Locating the elusive, yet vital, insights into how people manage and live with their medical conditions

- PMLiVE

The trouble with insights

Using health psychology to address medicines adherence is a rapidly developing area, but one that is poorly understood by many companies operating in the space

- PMLiVE

Guiding decisions

How the ever-changing face of market research continues to impact the healthcare industry

- PMLiVE

GW ascendant as epilepsy drug clears phase III trial

Epidiolex proves effective in controlling seizures in children with Dravet syndrome

- PMLiVE

How AbbVie Care is putting patients at the centre

And why this is good news for everyone

- PMLiVE

EMA starts review of Gilead’s Zydelig on ‘serious’ safety concerns

Trials of the leukaemia treatment have been halted while the investigation is underway

- PMLiVE

Pharma’s reputation rises, but pricing still a sore point

Patient group survey sees the industry's corporate reputation increase

- PMLiVE

A better direction

Could behavioural science be the key to improving patient outcomes?

- PMLiVE

The new EU clinical trial lay summaries

New regulations will require both a trial summary and a lay person’s summary

The new EU clinical trial lay summaries

New regulations will require both a trial summary and a lay person’s summary

- PMLiVE

Genital herpes vaccine candidate promising in phase II

Genocea Biosciences’ GEN-003 found to reduce recurrence and transmission of the virus

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links